0001209191-18-045591.txt : 20180806 0001209191-18-045591.hdr.sgml : 20180806 20180806181937 ACCESSION NUMBER: 0001209191-18-045591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180802 FILED AS OF DATE: 20180806 DATE AS OF CHANGE: 20180806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18995842 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CRO Common Stock 2018-08-02 4 M 0 2155 91.05 A 48817 D Common Stock 2018-08-02 4 S 0 700 175.06 D 48117 D Common Stock 2018-08-02 4 S 0 400 175.88 D 47717 D Common Stock 2018-08-02 4 S 0 400 176.95 D 47317 D Common Stock 2018-08-02 4 S 0 355 178.49 D 46962 D Common Stock 2018-08-02 4 S 0 300 179.38 D 46662 D Common Stock 2018-08-03 4 M 0 1942 86.52 A 48604 D Common Stock 2018-08-03 4 S 0 1142 174.50 D 47462 D Common Stock 2018-08-03 4 S 0 700 175.86 D 46762 D Common Stock 2018-08-03 4 S 0 100 176.69 D 46662 D Common Stock 882 I 401(k) Common Stock 12215 I Held in Trust Stock Option (Right to Buy) 91.05 2018-08-02 4 M 0 2155 0.00 D 2026-02-01 Common Stock 2155 12932 D Stock Option (Right to Buy) 86.52 2018-08-03 4 M 0 1942 0.00 D 2027-02-02 Common Stock 1942 19416 D Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $175.06 (range $174.47 to $175.43). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $175.88 (range $175.52 to $176.10). Open market sales reported on this line occurred at a weighted average price of $176.95 (range $176.62 to $177.21). Open market sales reported on this line occurred at a weighted average price of $178.49 (range $178.09 to $178.77). Open market sales reported on this line occurred at a weighted average price of $179.38 (range $179.17 to $179.49). Open market sales reported on this line occurred at a weighted average price of $174.50 (range $174.17 to $175.07). Open market sales reported on this line occurred at a weighted average price of $175.86 (range $175.57 to $176.30). The option vests in 16 quarterly installments from 2/2/2016. The option vests in 16 quarterly installments from 2/3/2017. /s/ Stephen Migausky, Attorney-in-Fact 2018-08-06